Northern Trust’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $123K | Buy |
115,657
+8,311
| +8% | +$8.81K | ﹤0.01% | 4065 |
|
2025
Q1 | $117K | Buy |
107,346
+6
| +0% | +$7 | ﹤0.01% | 4080 |
|
2024
Q4 | $162K | Buy |
107,340
+20,190
| +23% | +$30.5K | ﹤0.01% | 4047 |
|
2024
Q3 | $130K | Sell |
87,150
-236,560
| -73% | -$352K | ﹤0.01% | 3995 |
|
2024
Q2 | $524K | Sell |
323,710
-14,424
| -4% | -$23.4K | ﹤0.01% | 3493 |
|
2024
Q1 | $575K | Buy |
338,134
+10,910
| +3% | +$18.5K | ﹤0.01% | 3520 |
|
2023
Q4 | $1.01M | Sell |
327,224
-12,505
| -4% | -$38.8K | ﹤0.01% | 3310 |
|
2023
Q3 | $2.09M | Buy |
339,729
+18,931
| +6% | +$116K | ﹤0.01% | 2915 |
|
2023
Q2 | $2.01M | Buy |
320,798
+12,292
| +4% | +$76.9K | ﹤0.01% | 3001 |
|
2023
Q1 | $1.47M | Sell |
308,506
-12,227
| -4% | -$58.3K | ﹤0.01% | 3078 |
|
2022
Q4 | $2.79M | Buy |
320,733
+4,215
| +1% | +$36.7K | ﹤0.01% | 2818 |
|
2022
Q3 | $3.77M | Buy |
316,518
+3,381
| +1% | +$40.2K | ﹤0.01% | 2658 |
|
2022
Q2 | $4.46M | Buy |
313,137
+67,379
| +27% | +$960K | ﹤0.01% | 2594 |
|
2022
Q1 | $5.12M | Sell |
245,758
-3,535
| -1% | -$73.6K | ﹤0.01% | 2575 |
|
2021
Q4 | $5.76M | Sell |
249,293
-3,783
| -1% | -$87.4K | ﹤0.01% | 2606 |
|
2021
Q3 | $7.54M | Sell |
253,076
-6,439
| -2% | -$192K | ﹤0.01% | 2474 |
|
2021
Q2 | $8.87M | Buy |
259,515
+97,688
| +60% | +$3.34M | ﹤0.01% | 2455 |
|
2021
Q1 | $5.32M | Buy |
161,827
+5,549
| +4% | +$183K | ﹤0.01% | 2706 |
|
2020
Q4 | $9.61M | Buy |
156,278
+140,300
| +878% | +$8.63M | ﹤0.01% | 2267 |
|
2020
Q3 | $567K | Buy |
+15,978
| New | +$567K | ﹤0.01% | 3577 |
|